{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T17:39:50Z","timestamp":1793209190263,"version":"4.5.0"},"reference-count":42,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,8,22]],"date-time":"2025-08-22T00:00:00Z","timestamp":1755820800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82274315"],"award-info":[{"award-number":["82274315"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Cisplatin (DDP) is a clinical first-line chemotherapy drug for hepatocellular carcinoma (HCC), but treatment is often ineffective due to drug resistance. Yes-associated protein 1 (YAP1)  is a critical regulator\/factor in HCC tumor progression. Our previous research showed that DDP promoted the expression of YAP1 in mice bearing H22 cell in situ liver tumors, which might be related to the poor therapeutic effect of DDP.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods and results<\/jats:title><jats:p>DDP could inhibit tumor growth and decrease tumor volume in DEN\/TCPOBOP-induced HCC mice, increase the number of CD8<jats:sup>+<\/jats:sup> T cells in the tumor, reduce the proportion of PD-1<jats:sup>+<\/jats:sup>CD8<jats:sup>+<\/jats:sup> T cells in the peripheral blood and spleen of mice, and reduce the immune exhaustion of the tumor microenvironment in HCC. Of note, that DDP treatment activated YAP1 expression in HCC cells. In addition, using a murine model of subcutaneous transplantation of HCC cells, it was found that the combined use of the YAP1 inhibitor, verteporfin, and DDP led to significant tumor regression. Inhibition of YAP1 reduced activation of the cGAS-STING pathway by DDP treatment. Furthermore, bioinformatics analysis revealed that YAP1 was positively correlated with cGAS and STING in HCC tissues. We further confirmed the correlation of YAP1 with cGAS-STING in HCC using two models: DEN\/TCPOBOP induction of HCC in hepatocyte-specific Y<jats:italic>ap1<\/jats:italic> knockout mice; and giving verteporfin treatment to mice with subcutaneously transplanted HCC tumors. Inhibiting the expression of YAP1 in HCC tissues can reduce the expression of cGAS-STING and enhance the therapeutic effect of cisplatin.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>The combination of YAP1 inhibitor, verteporfin and DDP enhances anti-tumor immunity by regulating the interaction between YAP1 and cGAS-STING in the tumor microenvironment, providing new insights into a combined chemotherapy strategy for HCC.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fimmu.2025.1658042","type":"journal-article","created":{"date-parts":[[2025,8,22]],"date-time":"2025-08-22T04:10:34Z","timestamp":1755835834000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":5,"title":["Verteporfin inhibits the cGAS-STING pathway and improves the tumor microenvironment during cisplatin treatment in hepatocellular carcinoma"],"prefix":"10.3389","volume":"16","author":[{"given":"Yi","family":"Gong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yajun","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuting","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyong","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanli","family":"Gong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhihan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanguang","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junlan","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle Xinyue","family":"Zou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinli","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,8,22]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"394","DOI":"10.3322\/caac.21492","article-title":"Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"68","author":"Bray","year":"2018","journal-title":"CA Cancer J Clin"},{"key":"B2","doi-asserted-by":"publisher","first-page":"1477","DOI":"10.1186\/1477-7819-11-78","article-title":"Complete remission by transarterial infusion with cisplatin for recurrent bile duct tumor thrombus of hepatocellular carcinoma: report of a case","volume":"11","author":"Ebara","year":"2013","journal-title":"World J Surg Oncol"},{"key":"B3","doi-asserted-by":"publisher","first-page":"4136","DOI":"10.3390\/ijms20174136","article-title":"New insights into mechanisms of cisplatin resistance: from tumor cell to microenvironment","volume":"20","author":"Chen","year":"2019","journal-title":"Int J Mol Sci"},{"key":"B4","doi-asserted-by":"publisher","first-page":"154715","DOI":"10.1016\/j.phymed.2023.154715","article-title":"Aucubin enhances the antitumor activity of cisplatin through the inhibition of PD-L1 expression in hepatocellular carcinoma","volume":"112","author":"Gao","year":"2023","journal-title":"Phytomedicine"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20130208","article-title":"Blimp-1 represses CD8 T cell expression of PD-1 using a feed-forward transcriptional circuit during acute viral infection","volume":"211","author":"Lu","year":"2014","journal-title":"J Exp Med"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1038\/s41571-021-00473-5","article-title":"PD-L1 as a biomarker of response to immune-checkpoint inhibitors","volume":"18","author":"Doroshow","year":"2021","journal-title":"Nat Rev Clin Oncol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccell.2020.07.004","article-title":"Clinical challenges of immune checkpoint inhibitors","volume":"38","author":"de Miguel","year":"2020","journal-title":"Cancer Cell"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2017.00561","article-title":"PD-1 and PD-L1 checkpoint signaling inhibition for cancer immunotherapy: mechanism, combinations, and clinical outcome","volume":"8","author":"Alsaab","year":"2017","journal-title":"Front Pharmacol"},{"key":"B9","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1186\/s12943-018-0864-3","article-title":"Biomarkers for predicting efficacy of PD-1\/PD-L1 inhibitors","volume":"17","author":"Yi","year":"2018","journal-title":"Mol cancer"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2011.02.031","article-title":"Yap1 acts downstream of \u03b1-catenin to control epidermal proliferation","volume":"144","author":"Schlegelmilch","year":"2011","journal-title":"Cell"},{"key":"B11","doi-asserted-by":"publisher","first-page":"111139","DOI":"10.1016\/j.cbi.2024.111139","article-title":"Yes-associated protein inhibition ameliorates carbon tetrachloride-induced acute liver injury in mice by reducing VDR","volume":"399","author":"Wang","year":"2024","journal-title":"Chem Biol Interact"},{"key":"B12","doi-asserted-by":"publisher","first-page":"175241","DOI":"10.1016\/j.ejphar.2022.175241","article-title":"Pharmacological targeting of cGAS\/STING-YAP axis suppresses pathological angiogenesis and ameliorates organ fibrosis","volume":"932","author":"Wang","year":"2022","journal-title":"Eur J Pharmacol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1007\/s12094-022-02826-7","article-title":"An overview of the crosstalk between YAP and cGAS-STING signaling in non-small cell lung cancer: it takes two to tango","volume":"24","author":"Hao","year":"2022","journal-title":"Clin Transl Oncol"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2021-004006","article-title":"Hyperbaric oxygen facilitates teniposide-induced cGAS-STING activation to enhance the antitumor efficacy of PD-1 antibody in HCC","volume":"10","author":"Li","year":"2022","journal-title":"J immunotherapy Cancer"},{"key":"B15","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1002\/hep.28874","article-title":"IL-6 trans-signaling is essential for the development of hepatocellular carcinoma in mice","volume":"65","author":"Bergmann","year":"2017","journal-title":"Hepatology"},{"key":"B16","doi-asserted-by":"publisher","first-page":"116294","DOI":"10.1016\/j.bcp.2024.116294","article-title":"Dihydroartemisinin breaks the positive feedback loop of YAP1 and GLUT1-mediated aerobic glycolysis to boost the CD8(+) effector T cells in hepatocellular carcinoma","volume":"225","author":"Gao","year":"2024","journal-title":"Biochem Pharmacol"},{"key":"B17","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1007\/s11010-020-03861-0","article-title":"Cisplatin promotes the expression level of PD-L1 in the microenvironment of hepatocellular carcinoma through YAP1","volume":"475","author":"Li","year":"2020","journal-title":"Mol Cell Biochem"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.00101","article-title":"Regulation of CD8(+) T cells and antitumor immunity by notch signaling","volume":"9","author":"Tsukumo","year":"2018","journal-title":"Front Immunol"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2019.07.044","article-title":"Systematic immunotherapy target discovery using genome-scale in vivo CRISPR screens in CD8 T cells","volume":"178","author":"Dong","year":"2019","journal-title":"Cell"},{"key":"B20","doi-asserted-by":"publisher","first-page":"152171","DOI":"10.1016\/j.acthis.2024.152171","article-title":"Dihydroartemisinin breaks the immunosuppressive tumor niche during cisplatin treatment in Hepatocellular carcinoma","volume":"126","author":"Yang","year":"2024","journal-title":"Acta Histochem"},{"key":"B21","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1158\/2159-8290.CD-19-0761","article-title":"The cytosolic DNA-sensing cGAS-STING pathway in cancer","volume":"10","author":"Kwon","year":"2020","journal-title":"Cancer discovery"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2022-004763","article-title":"Targeting of GSDMD sensitizes HCC to anti-PD-1 by activating cGAS pathway and downregulating PD-L1 expression","volume":"10","author":"Lv","year":"2022","journal-title":"J\u00a0immunotherapy Cancer"},{"key":"B23","doi-asserted-by":"publisher","first-page":"468","DOI":"10.3390\/cells8050468","article-title":"Role of the hippo pathway in fibrosis and cancer","volume":"8","author":"Kim","year":"2019","journal-title":"Cells"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2018.10.001","article-title":"Comprehensive molecular characterization of the hippo signaling pathway in cancer","volume":"25","author":"Wang","year":"2018","journal-title":"Cell Rep"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1002\/ptr.v37.5","article-title":"Dihydroartemisinin broke the tumor immunosuppressive microenvironment by inhibiting YAP1 expression to enhance anti-PD-1 efficacy","volume":"37","author":"Peng","year":"2023","journal-title":"Phytother Res"},{"key":"B26","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1186\/s40425-019-0814-7","article-title":"PD1(Hi) CD8(+) T cells correlate with exhausted signature and poor clinical outcome in hepatocellular carcinoma","volume":"7","author":"Ma","year":"2019","journal-title":"J immunotherapy cancer"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2017.07.007","article-title":"Hippo effector YAP directly regulates the expression of PD-L1 transcripts in EGFR-TKI-resistant lung adenocarcinoma","volume":"491","author":"Lee","year":"2017","journal-title":"Biochem Biophys Res Commun"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.7717\/peerj.11200","article-title":"Cisplatin-resistant HepG2 cell-derived exosomes transfer cisplatin resistance to cisplatin-sensitive cells in HCC","volume":"9","author":"Tang","year":"2021","journal-title":"PeerJ"},{"key":"B29","doi-asserted-by":"publisher","first-page":"111291","DOI":"10.1016\/j.cbi.2024.111291","article-title":"Enhancing cisplatin efficacy in hepatocellular carcinoma with selenocystine: The suppression of DNA repair and inhibition of proliferation in hepatoma cells","volume":"405","author":"Wu","year":"2024","journal-title":"Chem Biol Interact"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.21873\/anticanres.13281","article-title":"Cisplatin augments antitumor T-cell responses leading to a potent therapeutic effect in combination with PD-L1 blockade","volume":"39","author":"Wakita","year":"2019","journal-title":"Anticancer Res"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.16407","article-title":"The PD-1, PD-L1 expression and CD3+ T cell infiltration in relation to outcome in advanced gastric signet-ring cell carcinoma, representing a potential biomarker for immunotherapy","volume":"8","author":"Jin","year":"2017","journal-title":"Oncotarget"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.00409-07","article-title":"Upregulation of PD-1 expression on circulating and intrahepatic hepatitis C virus-specific CD8+ T cells associated with reversible immune dysfunction","volume":"81","author":"Golden-Mason","year":"2007","journal-title":"J Virol"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-16-3167","article-title":"PD-1 status in CD8(+) T cells associates with survival and anti-PD-1 therapeutic outcomes in head and neck cancer","volume":"77","author":"Kansy","year":"2017","journal-title":"Cancer Res"},{"key":"B34","doi-asserted-by":"publisher","first-page":"017","DOI":"10.1038\/s41598-017-08479-9","article-title":"Prognostic value of programmed cell death protein 1 expression on CD8+ T lymphocytes in pancreatic cancer","volume":"7","author":"Shen","year":"2017","journal-title":"Sci Rep"},{"key":"B35","doi-asserted-by":"publisher","first-page":"019","DOI":"10.1186\/s40425-019-0499-y","article-title":"Prognostic value of CD8\u2009+\u2009PD-1+ immune infiltrates and PDCD1 gene expression in triple negative breast cancer","volume":"7","author":"Yeong","year":"2019","journal-title":"J Immunother Cancer"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2015.04.031","article-title":"Direct activation of STING in the tumor microenvironment leads to potent and systemic tumor regression and immunity","volume":"11","author":"Corrales","year":"2015","journal-title":"Cell Rep"},{"key":"B37","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.trsl.2024.03.004","article-title":"Reversal of cisplatin resistance in oral squamous cell carcinoma by piperlongumine loaded smart nanoparticles through inhibition of Hippo-YAP signaling pathway","volume":"268","author":"Sa","year":"2024","journal-title":"Transl Res"},{"key":"B38","doi-asserted-by":"publisher","first-page":"110387","DOI":"10.1016\/j.jbc.2025.110387","article-title":"TFAP2C drives cisplatin resistance in bladder cancer by upregulating YAP and activating \u03b2-catenin signaling","volume":"301","author":"Pan","year":"2025","journal-title":"J\u00a0Biol Chem"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1038\/s41401-024-01342-4","article-title":"Adaptor protein CEMIP reduces the chemosensitivity of small cell lung cancer via activation of an SRC-YAP oncogenic module","volume":"45","author":"Shen","year":"2024","journal-title":"Acta Pharmacol Sin"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.3802\/jgo.2021.32.e77","article-title":"Downregulation of LINC01508 contributes to cisplatin resistance in ovarian cancer via the regulation of the Hippo-YAP pathway","volume":"32","author":"Xiao","year":"2021","journal-title":"J Gynecol Oncol"},{"key":"B41","doi-asserted-by":"publisher","first-page":"3011","DOI":"10.3390\/cells11193011","article-title":"Activation of cGAS-STING signal to inhibit the proliferation of bladder cancer: the immune effect of cisplatin","volume":"11","author":"Fu","year":"2022","journal-title":"Cells"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2014.10.017","article-title":"STING-dependent cytosolic DNA sensing mediates innate immune recognition of immunogenic tumors","volume":"41","author":"Woo","year":"2014","journal-title":"Immunity"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1658042\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,22]],"date-time":"2025-08-22T04:10:35Z","timestamp":1755835835000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1658042\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,22]]},"references-count":42,"alternative-id":["10.3389\/fimmu.2025.1658042"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2025.1658042","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,22]]},"article-number":"1658042"}}